<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34364999</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>09</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1542-7714</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>20</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association</Title>
          <ISOAbbreviation>Clin Gastroenterol Hepatol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>When Is Patient Behavior Indicative of Avoidant Restrictive Food Intake Disorder (ARFID) Vs Reasonable Response to Digestive Disease?</ArticleTitle>
        <Pagination>
          <StartPage>1241</StartPage>
          <EndPage>1250</EndPage>
          <MedlinePgn>1241-1250</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cgh.2021.07.045</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S1542-3565(21)00827-2</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND &amp; AIMS" NlmCategory="OBJECTIVE">Dietary modification is common in patients with digestive diseases to improve symptoms; however, food avoidance can become problematic. Avoidant Restrictive Food Intake Disorder (ARFID) is characterized as failure to meet one's nutritional needs owing to sensory hypersensitivity, lack of interest in eating, or fear of aversive consequences from eating, and is associated with negative medical and psychosocial outcomes. This study characterizes ARFID behaviors in adults with achalasia, celiac sprue, eosinophilic esophagitis, and inflammatory bowel disease.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">In this cross-sectional study, 289 adults aged 18 and older completed self-report measures evaluating use of dietary treatment, ARFID symptoms, and psychosocial outcomes. Primary analyses investigated the occurrence of ARFID in patients with achalasia, celiac, eosinophilic esophagitis, and inflammatory bowel disease. Secondary analyses explored the associations between ARFID symptoms and clinical and psychosocial outcomes.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">More than half (53.7%) of the total sample met the diagnostic criteria for ARFID based on the Nine-Item ARFID Screen (NIAS), with 78.4% of patients with achalasia meeting criteria. Patients on a physician-directed diet showed greater fear of gastrointestinal symptoms (P = .025), less interest in food (P = .046), and a higher total NIAS score (P = .045). For patients using dietary therapy, those who had met with a dietitian reported higher NIAS scores (P = .039). Food avoidance/restriction was associated with increased anxiety and depression, and diminished health-related quality of life.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">It is likely that ARFID rates, as measured by the NIAS, are inflated in these 4 patient groups. These findings highlight the need for updated assessments of ARFID in patients with complex digestive diseases.</AbstractText>
          <CopyrightInformation>Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Fink</LastName>
            <ForeName>Margaret</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Simons</LastName>
            <ForeName>Madison</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tomasino</LastName>
            <ForeName>Kathryn</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pandit</LastName>
            <ForeName>Anjali</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Taft</LastName>
            <ForeName>Tiffany</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Electronic address: ttaft@northwestern.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>P01 DK117824</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>UL1 TR001422</GrantID>
            <Acronym>TR</Acronym>
            <Agency>NCATS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>08</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Clin Gastroenterol Hepatol</MedlineTA>
        <NlmUniqueID>101160775</NlmUniqueID>
        <ISSNLinking>1542-3565</ISSNLinking>
      </MedlineJournalInfo>
      <SupplMeshList>
        <SupplMeshName Type="Disease" UI="C535952">Eosinophilic enteropathy</SupplMeshName>
      </SupplMeshList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000080146" MajorTopicYN="Y">Avoidant Restrictive Food Intake Disorder</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004751" MajorTopicYN="N">Enteritis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004802" MajorTopicYN="N">Eosinophilia</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057765" MajorTopicYN="Y">Eosinophilic Esophagitis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004931" MajorTopicYN="Y">Esophageal Achalasia</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001068" MajorTopicYN="Y">Feeding and Eating Disorders</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005756" MajorTopicYN="Y">Gastritis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015212" MajorTopicYN="Y">Inflammatory Bowel Diseases</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">ARFID</Keyword>
        <Keyword MajorTopicYN="N">Diet</Keyword>
        <Keyword MajorTopicYN="N">Digestive Disease</Keyword>
      </KeywordList>
      <CoiStatement><b>Conflicts of Interest:</b> Tiffany Taft has 100% ownership in Oak Park Behavioral Medicine LLC.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2023</Year>
          <Month>6</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>8</Day>
          <Hour>20</Hour>
          <Minute>36</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34364999</ArticleId>
        <ArticleId IdType="mid">NIHMS1759577</ArticleId>
        <ArticleId IdType="pmc">PMC8816975</ArticleId>
        <ArticleId IdType="doi">10.1016/j.cgh.2021.07.045</ArticleId>
        <ArticleId IdType="pii">S1542-3565(21)00827-2</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Levine A, Rhodes JM, Lindsay JO, et al.
Dietary Guidance From the International Organization for the Study of Inflammatory Bowel Diseases. Clinical Gastroenterology and Hepatology
2020;18:1381–1392.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32068150</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kahrilas PJ, Bredenoord AJ, Fox M, et al.
The Chicago Classification of esophageal motility disorders, v3.0.
Neurogastroenterol Motil
2015;27:160–74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4308501</ArticleId>
            <ArticleId IdType="pubmed">25469569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marsh A, Kinneally J, Robertson T, et al.
Food avoidance in outpatients with Inflammatory Bowel Disease - Who, what and why. Clin Nutr ESPEN
2019;31:10–16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31060826</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cohen AB, Lee D, Long MD, et al.
Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease. Dig Dis Sci
2013;58:1322–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3552110</ArticleId>
            <ArticleId IdType="pubmed">22923336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Casanova MJ, Chaparro M, Molina B, et al.
Prevalence of Malnutrition and Nutritional Characteristics of Patients With Inflammatory Bowel Disease. J Crohns Colitis
2017;11:1430–1439.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28981652</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Limdi JK, Aggarwal D, McLaughlin JT. Dietary Practices and Beliefs in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis
2016;22:164–70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26383912</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murray HB, Bailey AP, Keshishian AC, et al.
Prevalence and Characteristics of Avoidant/Restrictive Food Intake Disorder in Adult Neurogastroenterology Patients. Clin Gastroenterol Hepatol
2020;18:1995–2002.e1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31669056</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harer K, Baker J, Reister N, et al.
Avoidant/Restrictive Food Intake Disorder in the Adult Gastroenterology Population: An Under-Recognized Diagnosis?: 417. The American journal of gastroenterology
2018;113:S247–S248.</Citation>
        </Reference>
        <Reference>
          <Citation>Harer KN, Jagielski CH, Riehl ME, et al.
272 – Avoidant/Restrictive Food Intake Disorder Among Adult Gastroenterology Behavioral Health Patients: Demographic and Clinical Characteristics. Gastroenterology (New York, N.Y. 1943)
2019;156:S-53–S-53.</Citation>
        </Reference>
        <Reference>
          <Citation>Zia JK, Riddle M, DeCou CR, et al.
Prevalence of Eating Disorders, Especially DSM-5's Avoidant Restrictive Food Intake Disorder, in Patients with Functional Gastrointestinal Disorders: A Cross-Sectional Online Survey. Gastroenterology (New York, N.Y. 1943)
2017;152:S715–S716.</Citation>
        </Reference>
        <Reference>
          <Citation>Burton Murray H, Jehangir A, Silvernale CJ, et al.
Avoidant/restrictive food intake disorder symptoms are frequent in patients presenting for symptoms of gastroparesis. Neurogastroenterol Motil
2020;32:e13931.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32677153</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zickgraf HF, Ellis JM. Initial validation of the Nine Item Avoidant/Restrictive Food Intake disorder screen (NIAS): A measure of three restrictive eating patterns. Appetite
2018;123:32–42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29208483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bryant-Waugh R, Micali N, Cooke L, et al.
Development of the Pica, ARFID, and Rumination Disorder Interview, a multi-informant, semi-structured interview of feeding disorders across the lifespan: A pilot study for ages 10–22. The International journal of eating disorders
2019;52:378–387.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6453710</ArticleId>
            <ArticleId IdType="pubmed">30312485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lim HS, Kim SK, Hong SJ. Food Elimination Diet and Nutritional Deficiency in Patients with Inflammatory Bowel Disease. Clin Nutr Res
2018;7:48–55.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5796923</ArticleId>
            <ArticleId IdType="pubmed">29423389</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morton H, Pedley KC, Stewart RJC, et al.
Inflammatory Bowel Disease: Are Symptoms and Diet Linked?
Nutrients
2020;12.</Citation>
        </Reference>
        <Reference>
          <Citation>Harshman SG, Wons O, Rogers MS, et al.
A Diet High in Processed Foods, Total Carbohydrates and Added Sugars, and Low in Vegetables and Protein Is Characteristic of Youth with Avoidant/Restrictive Food Intake Disorder. Nutrients
2019;11:2013.</Citation>
        </Reference>
        <Reference>
          <Citation>Vagianos K, Bector S, McConnell J, et al.
Nutrition assessment of patients with inflammatory bowel disease. JPEN J Parenter Enteral Nutr
2007;31:311–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17595441</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
